Amarin Corp PLC (AMRN) stock
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)
Close on Nov 18, 2026Market cap $248.90MP/E –Yield –
Amarin operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Amarin's operating income for the twelve months ending Sep 30, 2026 was -$32.03M. For fiscal 2025 it was -$50.17M. The highest annual figure on record is $10.50M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$50.17M | – |
| FY2024 | Dec 31, 2024 | -$91.80M | – |
| FY2023 | Dec 31, 2023 | -$67.59M | – |
| FY2022 | Dec 31, 2022 | -$105.87M | -1108.1% |
| FY2021 | Dec 31, 2021 | $10.50M | – |
| FY2020 | Dec 31, 2020 | -$19.66M | – |
| FY2019 | Dec 31, 2019 | -$24.28M | – |
| FY2018 | Dec 31, 2018 | -$108.23M | – |
| FY2017 | Dec 31, 2017 | -$45.56M | – |
| FY2016 | Dec 31, 2016 | -$65.63M | – |
| FY2015 | Dec 31, 2015 | -$98.22M | – |
| FY2014 | Dec 31, 2014 | -$95.96M | – |
| FY2013 | Dec 31, 2013 | -$182.11M | – |
| FY2012 | Dec 31, 2012 | -$116.75M | – |
| FY2011 | Dec 31, 2011 | -$44.16M | – |
| FY2010 | Dec 31, 2010 | -$45.10M | – |
| FY2009 | Dec 31, 2009 | -$34.04M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$2.36M | – |
| Q2 FY2026 | Jun 30, 2026 | -$12.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$11.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.33M | – |
| Q3 FY2025 | Sep 30, 2025 | -$11.10M | – |
| Q2 FY2025 | Jun 30, 2025 | -$15.99M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.76M | – |
| Q4 FY2024 | Dec 31, 2024 | -$52.52M | – |
| Q3 FY2024 | Sep 30, 2024 | -$25.17M | – |
| Q2 FY2024 | Jun 30, 2024 | -$524.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.58M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.84M | – |
| Q3 FY2023 | Sep 30, 2023 | -$21.45M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$17.34M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.59M | -159.4% |
| Q3 FY2022 | Sep 30, 2022 | -$5.14M | – |
| Q2 FY2022 | Jun 30, 2022 | -$62.83M | -816.2% |
| Q1 FY2022 | Mar 31, 2022 | -$28.31M | – |
| Q4 FY2021 | Dec 31, 2021 | $16.13M | +125.4% |
| Q3 FY2021 | Sep 30, 2021 | -$13.07M | – |
| Q2 FY2021 | Jun 30, 2021 | $8.77M | +111.1% |
| Q1 FY2021 | Mar 31, 2021 | -$1.33M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.16M | +30.4% |
| Q3 FY2020 | Sep 30, 2020 | -$6.94M | – |
| Q2 FY2020 | Jun 30, 2020 | $4.16M | – |
| Q1 FY2020 | Mar 31, 2020 | -$24.03M | – |
| Q4 FY2019 | Dec 31, 2019 | $5.49M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.51M | – |
| Q1 FY2019 | Mar 31, 2019 | -$22.74M | – |
| Q4 FY2018 | Dec 31, 2018 | -$31.77M | – |
| Q3 FY2018 | Sep 30, 2018 | -$22.25M | – |
| Q2 FY2018 | Jun 30, 2018 | -$32.31M | – |
| Q1 FY2018 | Mar 31, 2018 | -$21.90M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$11.40M | – |
| Q1 FY2017 | Mar 31, 2017 | -$18.56M | – |
| Q4 FY2016 | Dec 31, 2016 | -$12.86M | – |
See a number that looks wrong?